Locations:

University College Hospital, London

Who can enter the study?:

Patients with myeloma who are having high dose therapy and stem cell transplant.

What's involved?:

Participants are randomly assigned to two groups:

• the exercise group – where members will participate in an exercise programme in addition to usual care
•  the control group – where members will receive usual care

The exercise group undertake individually tailored aerobic and resistance exercise with behaviour change support during three phases of their treatment.

In phase 1, for 6-8 weeks before they come into hospital for their stem cell transplant they are asked to exercise three times per week. They are asked to take part in one session a week with a physiotherapist in a gym and complete two other sessions at home.

In phase 2, during their hospital stay, immediately after their stem cell transplant, the exercise participants are offered supervised exercise sessions with a physiotherapist three times per week.

In phase 3, for 3 months after they leave hospital the participants are asked to continue exercising at home three times per week. They receive weekly phone or Skype support from a physiotherapist to promote and support continuation or return to independent exercise in the post-transplant period.

Clinical Information
(for Medical Professionals):

The primary objective of this study is to evaluate the feasibility of delivering an exercise and behaviour change intervention prior to and during the usual high dose therapy and stem cell transplant treatment pathway in people with myeloma. Secondary objectives are to investigation of the possible effect of the intervention on a range of measures including fatigue, quality of life, physical activity and functional capacity.

For more information, click here.

Find out more:

Visit www.myeloma.org.uk for more information